Table of contents
November 2017 - Volume 1 - 1
Editorials
- Considerations in Medicine (1 November, 2017)
- Considering biosimilars in inflammatory diseases (1 November, 2017)
Review articles
- The biosimilar approval process: how different is it? (1 November, 2017)
- Biosimilars already approved and in development (1 November, 2017)
- Biosimilars: considerations for clinical practice (1 November, 2017)
- Considering biosimilar policy (1 November, 2017)